RecruitingNCT06984965

Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke

Role of Electroencephalogram (EEG) in Differentiation Between Ischemic and Hemorrhagic Stroke and as a Predictor of Post-stroke Recovery


Sponsor

Assiut University

Enrollment

300 participants

Start Date

Jun 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Searching electrical activity registered by EEG in acute ischemic and hemorrhagic stroke and comparing these parameters to the poststroke recovery patterns to investigate the role of EEG as a differentiation tool and as a predictor of post-stroke recovery.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria7

  • Age above 18 and below 80 years.
  • Acute Ischemic stroke: ischemic arteria cerebri media infarct confirmed by MRI.
  • Acute Hemorrhagic stroke: spontaneous intraparenchymal bleeding confirmed by CT.
  • Stroke onset <72 hours before expected time of performing EEG.
  • First-ever ischemic stroke.
  • Measurable deficit on the National Institute of Health Stroke Scale (NIHSS).
  • Able to give and sign informed consent.

Exclusion Criteria17

  • Transient Ischemic Attacks (TIAs).
  • Greater than 72 hours past the initial insult.
  • Patients with subarachnoid haemorrhage, traumatic haemorrhage (epidural/subdural bleeding), cerebral venous sinus thrombosis, indication for urgent neurosurgical intervention.
  • History of other central nervous system diseases.
  • Any signs unfit for MRI/EEG scan.
  • Injury or active infection of electrode cap placement area.
  • Claustrophobia; recognition disorder.
  • Known skull defect or head trauma.
  • Previous neurological procedure (metallic implant, brain pace, cranial operation history).
  • Significant physical impairment that would restrict the ability to use the portable EEG devices.
  • Presence of malignancy or systemic rheumatic disease
  • Non-stroke disease or lesion affecting the sensorimotor system.
  • Alcohol or drug addiction.
  • Presence of pump/shunt.
  • Presence of Malignancy.
  • Presence of severe cognitive impairment.
  • History of epilepsy or taking medication due to epilepsy.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Neurology Department, Faculty of Medicine, Assiut University

Asyut, Asyut Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06984965


Related Trials